Sort by
Refine Your Search
-
Category
-
Country
-
Program
-
Field
-
community Be surrounded by extraordinary ideas - and the people who discover them The Opportunity Are you ready to make a groundbreaking impact on the future of human health? The Australian Regenerative
-
health? The Australian Regenerative Medicine Institute (ARMI) at Monash University is seeking an exceptional, forward-thinking Senior Research Fellow / Associate Professor (Research) to join us as an EMBL
-
surrounded by extraordinary ideas - and the people who discover them The Opportunity Are you ready to make a groundbreaking impact on the future of human health? The Australian Regenerative Medicine Institute
-
The Department of Molecular Biology and Genetics and the Danish Research Institute of Translational Neuroscience (DANDRITE, Nordic-EMBL partnership in molecular medicine) at Aarhus University
-
. trachomatis, genetic manipulations of C. trachomatis and human cell lines, and the application of molecular genetic, microscopic, and cell biological assays for the analysis of intracellular host-pathogen
-
into microbial (including viral) pathogenesis, and provides excellent access to national research infrastructure, including cutting edge cryo-electron microscopy and animal biosafety level 3 (ABSL3) facilities. We
-
Leader on a nine-year, European Molecular Biology Laboratory (EMBL)-style appointment. We invite applications from candidates developing innovative and independent research programmes at the interface
-
Description Candida albicans is a major human fungal pathogen and the species most commonly associated with invasive candidiasis, a disease estimated to cause nearly one million deaths worldwide each year. A
-
through SAP Fiori https://msap.sap.helsinki.fi . For further information on the position, please contact Dr. Tuomo Hartonen ([email protected] ). A diverse and equitable study and work culture is
-
WORLD – TOGETHER! #HelsinkiUniCareers The Institute for Molecular Medicine Finland (FIMM) is an international research unit focusing on human genomics and personalized medicine at the Helsinki Institute